25
total announcements
530019.BO · 15 min delayed
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has received a Show Cause Notice from the Assistant Commissioner of Commercial taxes (Enforcement)-4, Mysore, proposing a demand of GST, interest, and penalty for the Financial Year 2022-2023. The company intends to file a detailed reply with documentary evidence and expects no financial or operational impact.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has published a newspaper advertisement regarding a special window for re-lodging transfer requests of physical shares and KYC updation and dematerialization of physical share certificates.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has received a Show Cause Notice from the Joint Commissioner, CGST Division, Roorkee, proposing a demand of GST, interest, and penalty for FY 2020-21 and 2021-22. The company plans to file a detailed reply and expects no financial or operational impact.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd held its 48th Annual General Meeting (AGM) on August 26, 2026, through video conferencing. All resolutions were passed with the requisite majority. The meeting was attended by 86 members, representing 7,07,21,051 equity shares. The company's financial and operational performance for the year was discussed.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd held its 48th Annual General Meeting (AGM) on August 26, 2026, through Video Conferencing (VC). All resolutions were passed with the requisite majority. The meeting was attended by 86 members representing 7,07,21,051 equity shares. The company has uploaded the proceedings, voting results, and scrutinizer's report on its website and National Securities Depositories Limited.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd announces USFDA approval for its new Isolator based fill and finish line, Line 3 at Contract manufacturing facility, Spokane, U.S.A.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd's shareholders have approved the re-appointment of Mr. Priyavrat Bhartia as Managing Director and Mr. Arjun Shanker Bhartia as Joint Managing Director, with both resolutions being passed with a 100% majority.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd's AGM/EGM announcement reports the outcome of a postal ballot, where two special resolutions were passed with the required majority. The resolutions concern the re-appointment of Mr. Priyavrat Bhartia as Managing Director and Mr. Arjun Shanker Bhartia as Joint Managing Director, along with their remuneration. The voting results show a high level of participation, with over 79% of total shares polled in favor of the resolutions.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has published unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, in the Financial Express and Hindustan & Jansatta newspapers.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced its Q1 FY27 results, with revenue growing 17% YoY to Rs. 2,229 Cr, driven by solid growth across all business segments. EBITDA margins declined due to unavailability of high-margin SPECT radiopharmaceutical products and higher operating expenses. The company expects EBITDA margins to expand from H2 FY27 onwards.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 671 crore and a net profit of Rs. 1 crore.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹671 crore and total income at ₹672 crore. The company's board of directors has approved the results, which will be posted on the company's website.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has scheduled one-on-one and group meetings with institutional investors from August 13-14, 2026, to discuss Q1 FY27 earnings presentation and financial results.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has postponed and rescheduled its Board meeting from August 7, 2026 to August 10, 2026, to consider and approve the Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The trading window for dealing in the company's securities remains closed from July 1, 2026 to August 12, 2026.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has published a newspaper advertisement regarding the notice of its 48th Annual General Meeting, e-voting, record date, and final dividend information.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced a potential deduction of tax at source (TDS) on the final dividend for FY 2025-26, subject to approval by shareholders at the ensuing AGM. The company has also provided details on the procedures to be followed by shareholders for submission of relevant forms and documents.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has dispatched letters to shareholders whose email IDs are not registered, providing a weblink to access the Annual Report for FY 2025-26 and Notice of the 48th Annual General Meeting along with TDS Communication.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has released its Business Responsibility and Sustainability Report for the financial year 2025-26, as required by SEBI regulations.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced its 48th Annual General Meeting (AGM) to be held on August 26, 2026, through video conferencing. The meeting will consider the audited financial statements for the year ended March 31, 2026, and re-appointment of directors, including Mr. Arjun Shanker Bhartia and Mr. Hari S. Bhartia. The company also proposes to declare a dividend of ₹5 per equity share.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced its 48th Annual General Meeting (AGM) to be held on August 26, 2026, through Video Conferencing/Other Audio-Visual Means (VC/OAVM). The AGM notice and annual report for the financial year 2025-26 have been sent to all members whose email addresses are registered with the company/RTA/depository participant(s). The company has provided the facility to vote by electronic means (remote e-voting as well as e-voting at the AGM) to the members who are holding shares on the cut-off date. The remote e-voting will commence at 9:00 a.m. (IST) on Sunday, August 23, 2026, and end at 5:00 p.m. (IST) on Tuesday, August 25, 2026.